GENE AND CELL THERAPIES TARGETING CNS DISORDERS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Table of Contents (Version-2026)

1. Research Objectives and Assumptions

• Research Objectives
• Assumptions
• Abbreviations

2. Market Purview

• Report Description
• Market Definition and Scope
• Executive Summary
• Market Snippet, By Therapy Type
• Market Snippet, By Indication
• Market Snippet, By Region
• Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

• Market Dynamics
• Drivers
• Restraints
• PEST Analysis
• PORTER’s Five Forces Analysis
• Market Opportunities
• Regulatory Scenario
• Key Developments
• Industry Trend

4. Global Gene And Cell Therapies Targeting CNS Disorders Market, By Therapy Type, 2026-2033, (USD Bn)

• Introduction
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Gene Therapy
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Cell Therapy
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends

5. Global Gene And Cell Therapies Targeting CNS Disorders Market, By Indication, 2026-2033, (USD Bn)

• Introduction
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 - 2033
• Segment Trends
• Alzheimer's Disease (AD)
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Huntington's Disease (HD)
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Parkinson's Disease (PD)
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Amyotrophic Lateral Sclerosis (ALS) & Motor Neuron Disease
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Multiple Sclerosis (MS)
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Adrenoleukodystrophy & Metachromatic Leukodystrophy
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Neuropathies
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends
• Batten Disease (BD)
• Market Share Analysis, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, 2021 – 2033
• Segment Trends

6. Global Gene And Cell Therapies Targeting CNS Disorders Market, By Region, 2026-2033, (USD Bn)

• Introduction
• Market Share Analysis, By Region, 2025, 2028, and 2033 (%)
• Y-o-Y Growth Analysis, For Region, 2021 - 2033
• North America
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Therapy Type, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• U.S.
• Canada
• Latin America
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Therapy Type, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• Brazil
• Argentina
• Mexico
• Rest of Latin America
• Europe
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Therapy Type, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• U.K.
• Germany
• Italy
• France
• Spain
• Russia
• Rest of Europe
• Asia Pacific
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Therapy Type, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• China
• India
• Japan
• ASEAN
• Australia
• South Korea
• Rest of Asia Pacific
• Middle East
• Market Share Analysis, By Country, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country, 2021 - 2033
• Market Size and Forecast, By Therapy Type, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• GCC Countries
• Israel
• Rest of Middle East
• Africa
• Market Share Analysis, By Country/Region, 2025, 2028 and 2033 (%)
• Y-o-Y Growth Analysis, For Country/Region, 2021 - 2033
• Market Size and Forecast, By Therapy Type, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Indication, 2026- 2033, (USD Bn)
• Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
• South Africa
• North Africa
• Central Africa

7. Competitive Landscape

• Heat Map Analysis
• Market Share Analysis (3x3 Matrix)
• Company Profiles
• Novartis
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• BrainStorm Cell Therapeutics
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Corestem
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Q Therapeutics
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Helixmith
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Rapa Therapeutics
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Neuroplast
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• StemCyte
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Ferrer Internacional
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Neuralstem
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Stemedica Cell Technologies
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Libella Gene Therapeutics
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Sangamo Therapeutics
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Hoffmann-La Roche
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• LSio Gene Therapies
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Eli Lilly and Company
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• NeuroGeneration
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• Brain Neurotherapy Bio (AskBio)
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates
• UniQure Biopharma
• Company Overview
• Product Type Portfolio
• Recent Developments/Updates

8. Analyst Recommendation

• Wheel of Fortune
• Analyst View
• Coherent Opportunity Map

9. Section

• References
• Research Methodology
• About Us and Sales Contact